The company provides the new PEPperCHIP® Peptide Microarray platform with an unrivaled content flexibility, signal quality and peptide diversity. PEPperPRINT’s unique peptide microarray platform is based on a completely new approach of combinatorial synthesis.Instead of using standard spotters or lithographic synthesis, this microarray platform prints amino acid microparticles with a custom 24-color laser printer.

PEPperPRINT’s product portfolio is complemented by the fully integrated PEPperMAP® Epitope Mapping and Serum Profiling Services, covering a wide range of applications from full epitope substitution scans to highly multiplexed epitope mappings. The PEPperMAP® service portfolio comprises all microarray-based experiments, data read-out and evaluation as well as a comprehensive report. PEPperMAP® Epitope Mapping and Serum Profiling Services enable you to benefit from the new state-of-the-art peptide microarray standard without any need for lab infrastructure in a cost effective manner.

OcellO offers cancer immunotherapy developers a new, highly powerful tool to select the most promising drugs at a very early stage in drug development. The availability of this new tool will empower the immunotherapy field, allowing the speedy progression of novel drugs towards clinical development – ultimately benefitting cancer patients.

PharmaLegacy is a CRO providing specialty in-vivo pharmacology services in Oncology (syngeneic, humanized mouse and monkey tumor models), Respiratory (such as acute lung Injury, lung fibrosis and monkey asthma models), Cardiovascular/Metabolic diseases such as liver fibrosis in NHP’s, NASH, stroke, thrombosis, diabetes, obesity in monkeys, and many other inflammatory models such as kidney fibrosis.